PMV Pharmaceuticals opens approximately 94% above IPO price and it is stated that the offering was upsized from 7.4M shares to ~11.8M shares and priced at the high-end of the expected range. What's your opinion in this?
It seems volatile and pretty cheap, but it's spikes are pretty constant, is this a good start? cause my friend suggested this, just need some 2nd opinion
